The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Final results of a phase I prospective trial evaluating the combination of stereotactic body radiotherapy (SBRT) with concurrent pembrolizumab in patients with metastatic non-small cell lung cancer (NSCLC) or melanoma.
 
Allison M. Campbell
No Relationships to Disclose
 
Roy S. Herbst
Consulting or Advisory Role - AstraZeneca; Genentech/Roche; Lilly; Merck; Pfizer
Research Funding - Genentech; Merck
 
Scott N. Gettinger
Consulting or Advisory Role - Alexion Pharmaceuticals; Bristol-Myers Squibb; Pfizer
Research Funding - ARIAD (Inst); Bristol-Myers Squibb (Inst); Genentech (Inst); Incyte (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Merck
 
Sarah B. Goldberg
Consulting or Advisory Role - AstraZeneca/MedImmune; Boehringer Ingelheim; Bristol-Myers Squibb; Lilly
Research Funding - AstraZeneca; Bristol-Myers Squibb (Inst); Clovis Oncology (Inst); Genentech (Inst); Immunogen (Inst); Kadmon (Inst); Merck (Inst); Pfizer (Inst); Pfizer (Inst)
 
Harriet M. Kluger
Consulting or Advisory Role - Alexion Pharmaceuticals; Biodesix; Corvus Pharmaceuticals; Genentech/Roche; Nektar; Pfizer
Research Funding - Bristol-Myers Squibb (Inst); Merck (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb
 
Anne C. Chiang
Consulting or Advisory Role - Abbvie; AstraZeneca; Genentech; Genentech/Roche
Research Funding - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Lilly; Millennium; OncoMed; Onyx; Stem CentRx
 
Rogerio Lilenbaum
Patents, Royalties, Other Intellectual Property - Section Editor for UpToDate
Travel, Accommodations, Expenses - Roche
 
Kurt A. Schalper
Honoraria - Takeda
Consulting or Advisory Role - Celgene; Shattuck Labs
Research Funding - Moderna Therapeutics; Navigate BioPharma; Onkaido Therapeutics; Pierre Fabre; Surface Oncology; Takeda; Tesaro; Vasculox
 
Ryan T. Sowell
Research Funding - Bristol-Myers Squibb; Gilead Sciences; MedImmune
 
Susan M. Kaech
No Relationships to Disclose
 
Roy H. Decker
Consulting or Advisory Role - AstraZeneca/MedImmune; Merck; Regeneron
Speakers' Bureau - AstraZeneca
Research Funding - Merck
Travel, Accommodations, Expenses - Physicans' Education Resource